Works matching IS 14786354 AND DT 2024 AND VI 26 AND IP 1

Results: 210
    1
    2
    3
    4

    Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03301-0
    By:
    • Torell, Agnes;
    • Stockfelt, Marit;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Akhter, Tansim;
    • Leonard, Dag;
    • Rönnblom, Lars;
    • Pihl, Sofia;
    • Saleh, Muna;
    • Sjöwall, Christopher;
    • Strevens, Helena;
    • Jönsen, Andreas;
    • Bengtsson, Anders A.;
    • Trysberg, Estelle;
    • Majczuk Sennström, Maria;
    • Zickert, Agneta;
    • Svenungsson, Elisabet;
    • Gunnarsson, Iva;
    • Bylund, Johan;
    • Jacobsson, Bo
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03305-w
    By:
    • Li, Jun;
    • Peng, Liying;
    • Wu, Lijun;
    • Ding, Yufang;
    • Duan, Xinwang;
    • Xu, Jian;
    • Wei, Wei;
    • Chen, Zhen;
    • Zhao, Cheng;
    • Yang, Min;
    • Jiang, Nan;
    • Zhang, Shangzhu;
    • Wang, Qian;
    • Tian, Xinping;
    • Li, Mengtao;
    • Zeng, Xiaofeng;
    • Zhao, Yan;
    • Zhao, Jiuliang
    Publication type:
    Article
    11
    12

    Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03297-7
    By:
    • Pollastro, Sabrina;
    • Musters, Anne;
    • Balzaretti, Giulia;
    • Niewold, Ilse;
    • van Schaik, Barbera;
    • Hässler, Signe;
    • Verhoef, Catharina M.;
    • Pallardy, Marc;
    • van Kampen, Antoine;
    • Mariette, Xavier;
    • de Vries, Niek;
    • Szely, Natacha;
    • Gleizes, Aude;
    • Abina, Salima Hacein-Bey;
    • Richez, Christophe;
    • Soubrier, Martin;
    • Avouac, Jérome;
    • Brocq, Olivier;
    • Sellam, Jérémie;
    • Huizinga, Tom
    Publication type:
    Article
    13
    14
    15

    Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03295-9
    By:
    • Liu, Jianyang;
    • Idborg, Helena;
    • Korotkova, Marina;
    • Lend, Kristina;
    • van Vollenhoven, Ronald;
    • Lampa, Jon;
    • Rudin, Anna;
    • Nordström, Dan;
    • Gudbjornsson, Bjorn;
    • Gröndal, Gerdur;
    • Uhlig, Till;
    • Hørslev-Petersen, Kim;
    • Lund Hetland, Merete;
    • Østergaard, Mikkel;
    • Nurmohamed, Michael;
    • Jakobsson, Per-Johan
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03275-z
    By:
    • Izmirly, Peter M.;
    • Kim, Mimi Y.;
    • Carlucci, Philip M.;
    • Preisinger, Katherine;
    • Cohen, Brooke Z.;
    • Deonaraine, Kristina;
    • Zaminski, Devyn;
    • Dall'Era, Maria;
    • Kalunian, Kenneth;
    • Fava, Andrea;
    • Belmont, H. Michael;
    • Wu, Ming;
    • Putterman, Chaim;
    • Anolik, Jennifer;
    • Barnas, Jennifer L.;
    • Diamond, Betty;
    • Davidson, Anne;
    • Wofsy, David;
    • Kamen, Diane;
    • James, Judith A.
    Publication type:
    Article
    22
    23
    24

    Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03287-9
    By:
    • Calvo-Gutiérrez, Jerusalem;
    • López-Medina, Clementina;
    • Otero-Varela, Lucía;
    • Escudero-Contreras, Alejandro;
    • Ortega-Castro, Rafaela;
    • Ladehesa-Pineda, Lourdes;
    • Campos, Cristina;
    • Bernabeu-Gonzalvez, Pilar;
    • Pérez-Gómez, Ana;
    • García-Dorta, Alicia;
    • Ruiz-Montesino, Dolores;
    • Pombo-Suarez, Manuel;
    • Ros-Vilamajo, Inmaculada;
    • Sánchez-Alonso, Fernando;
    • Castrejón, Isabel
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Association of biochemical markers with bone marrow lesion changes on imaging—data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-023-03253-x
    By:
    • Yu, Shirley P.;
    • Deveza, Leticia A.;
    • Kraus, Virginia B.;
    • Karsdal, Morten;
    • Bay-Jensen, Anne-Christine;
    • Collins, Jamie E.;
    • Guermazi, Ali;
    • Roemer, Frank W.;
    • Ladel, Christoph;
    • Bhagavath, Venkatesha;
    • Hunter, David J.
    Publication type:
    Article
    44
    45

    Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-023-03232-2
    By:
    • Aggarwal, Rohit;
    • Schessl, Joachim;
    • Charles-Schoeman, Christina;
    • Bata-Csörgő, Zsuzsanna;
    • Dimachkie, Mazen M.;
    • Griger, Zoltan;
    • Moiseev, Sergey;
    • Oddis, Chester V.;
    • Schiopu, Elena;
    • Vencovský, Jiri;
    • Beckmann, Irene;
    • Clodi, Elisabeth;
    • Levine, Todd
    Publication type:
    Article
    46

    The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study.

    Published in:
    Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-023-03249-7
    By:
    • Di Muzio, Claudia;
    • Di Cola, Ilenia;
    • Shariat Panahi, Azadeh;
    • Ursini, Francesco;
    • Iagnocco, Annamaria;
    • Giacomelli, Roberto;
    • Cipriani, Paola;
    • Ruscitti, Piero
    Publication type:
    Article
    47
    48
    49
    50